ARTICLE | Clinical News
PT001: Phase IIa data
January 11, 2010 8:00 AM UTC
In a double-blind, dose-ranging, U.S. Phase IIa trial in 33 patients, PT001 was well tolerated and displayed comparable bronchodilator efficacy and safety to that of Spiriva HandiHaler tiotropium bro...